# A Randomized Placebo-procedure Controlled Trial of the Enhancor System (PULmonary Artery Denervation) to Evaluate Safety and Efficacy in Patients With Combined Pre- and Post-capillary Pulmonary Hypertension Associated With Left Heart Disease

Study · id `cardio:ct-nct07214376` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT07214376](<https://clinicaltrials.gov/study/NCT07214376>), retrieved 18 November 2026. No person wrote or checked this page.

Also called: NCT07214376

Browse, organ or system: Heart; Blood vessels  
Browse, condition area: Coronary and vascular disease; Heart failure  

## In plain language

A trial with no phase registered on ClinicalTrials.gov. The registry status is recruiting. It plans to enroll 750 participants.

## Technical summary

Registry record NCT07214376. Randomized; double masking; primary purpose treatment. Start 2026-08-21 (actual); primary completion 2029-12-31 (anticipated). Results not posted.

## Key facts

- Design: Interventional study; randomized; double masking; primary purpose treatment
- Phase: Not applicable
- Enrolled: 750 participants (planned count; ClinicalTrials.gov record NCT07214376, source copy `cardio:ctgov-nct07214376-2026-11-10`, retrieved 2026-11-18)
- Started: 2026-08-21 (actual) (ClinicalTrials.gov record NCT07214376, source copy `cardio:ctgov-nct07214376-2026-11-10`, retrieved 2026-11-18)
- Primary completion: 2029-12-31 (anticipated) (ClinicalTrials.gov record NCT07214376, source copy `cardio:ctgov-nct07214376-2026-11-10`, retrieved 2026-11-18)
- Completion: 2031-12-31 (anticipated) (ClinicalTrials.gov record NCT07214376, source copy `cardio:ctgov-nct07214376-2026-11-10`, retrieved 2026-11-18)
- Countries: United States; China (ClinicalTrials.gov record NCT07214376, source copy `cardio:ctgov-nct07214376-2026-11-10`, retrieved 2026-11-18)
- Care setting: Not reported
- Registry status: "RECRUITING" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct07214376-2026-11-10`, retrieved 2026-11-18)

## The registry's words

- Brief title: A Randomized Placebo-procedure Controlled Trial of the Enhancor System (PULmonary Artery Denervation) to Evaluate Safety and Efficacy in Patients With Combined Pre- and Post-capillary Pulmonary Hypertension Associated With Left Heart Disease
- Acronym: The PULSE-LHD
- Condition: Pulmonary Hypertension
- Condition: Heart Failure With Reduced Ejection Fraction
- Condition: Hypertension
- Condition: Vascular Diseases
- Condition: Cardiovascular Diseases
- Condition: Heart Failure
- Condition: Heart Failure With Preserved Ejection Fraction
- Condition: Heart Failure With Mid Range Ejection Fraction
- Intervention (Device): Pulmonary Artery Denervation (PADN)
- Intervention (Device): Sham procedure control
- Lead sponsor: Pulnovo Medical, Inc.
- Lead sponsor class: INDUSTRY

## Connected pages

- Registry condition terms include this condition: Heart failure (`cardio:heart-failure`)
- Registry condition term reads as this condition, and the trial is coded with its broader condition: Heart failure with mildly reduced or preserved ejection fraction (`cardio:hfpef`)
- Registry condition terms include this condition: Pulmonary hypertension (`cardio:pulmonary-hypertension`)

## Provenance

Content hash: 62f99d07fc8e720a280491ecfff3c4386258b9d63aaf0512386c015bd865bad8
Last substantive edit: 2026-11-18
Evidence last checked: Not recorded
